Exact Sciences Corp (NAS:EXAS)
$ 53.49 0 (0%) Market Cap: 9.87 Bil Enterprise Value: 11.77 Bil PE Ratio: 0 PB Ratio: 3.14 GF Score: 78/100

Exact Sciences Corp at Goldman Sachs Global Healthcare Conference Transcript

Jun 11, 2019 / 06:20PM GMT
Release Date Price: $110.2 (-0.10%)
Patrick B. Donnelly
Goldman Sachs Group Inc., Research Division - Equity Analyst

We can look to get started here. Thanks for being here.

I am the -- Patrick Donnelly, the tools and diagnostics analyst here at Goldman. Happy to have Jeff Elliott, CFO of Exact science, with us today.

It's open Q&A, so feel free. If you have any questions, just raise your hand.

But Jeff, maybe just to start, if you can kind of talk through the most recent quarter, obviously great results from you guys so far this year. Maybe just recap what you're seeing out there and then we will dive right into the Q&A.

Jeffrey T. Elliott
Exact Sciences Corporation - CFO

Sure, happy to. And Patrick, thanks for having us back here. It's great to be back at the Goldman Sachs conference.

So Q1 was another good quarter for Exact Sciences. We had about 80% revenue growth and we ended the quarter with about 4.5% market share. So this is a huge market, which I think we'll talk more about. Today, there are over 85 million people in the U.S. who are on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot